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ABSTRACT 
 
 
Luminescent quantum dot nanoparticles have emerged as a highly effective 
alternative to organic fluorescence probes in a variety of applications employing the use of 
immunoconjugates.  In the present study, we have successfully used quantum dot technology 
for the immunofluorescent detection of intracellular stages of Toxoplasma gondii in a CV-1 
mammalian cell line. This assay will allow us to investigate the question of whether selenium 
and other antioxidants have a direct impact on the intracellular cycle of the parasite. A Lab-
Tek cell culture system was used to determine optimal concentrations of primary and 
secondary antibodies.  Infected CV-1 monolayers were fixed in 4% formalin and cell 
membranes were permeabilized with detergent prior to blocking and immune-labeling. The 
use of a mouse anti-T. gondii primary antiserum followed by quantum dot – conjugated 
secondary antibody (Goat anti-mouse IgG) resulted in a punctuate, intensely bright 
fluorescent labeling of intracellular tachyzoite stages with no evidence of photobleaching or 
fading. In addition, the application of cover slips using Cryoseal Mounting Media 60, 
allowed for the long term storage of stained slide preparations.  
 
 
 
 
 
 
 
 
INDEX WORDS: Immunology, Parasitology, Toxoplasma gondii, Quantum Dot 
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INTRODUCTION 
 
 Toxoplasma gondii is an Apicomplexan protozoan parasite that causes a disease 
known as toxoplasmosis. Infection is generally chronic and asymptomatic in individuals with 
a strong immune system. On the other hand, infection can be reactivated in individuals who 
are immunocompromised, causing various types of neuropathology.   Toxoplasma gondii 
infection is also an important cause of miscarriage in pregnant women, and serious birth 
defects in newborns. Toxoplasmosis is prevalent worldwide in many mammalian species as 
well as birds. Cats are the only definitive host for this parasite. T. gondii has three stages in 
its life cycle: tachyzoites, present during the acute phase of infection; bradyzoites, present 
within tissue cysts during the chronic phase of infection; and oocysts produced during the 
sexual cycle within the gastrointestinal tract of cats. Tachyzoites have a crescent shape, and 
they do not have a visible way of locomotion such as pseudopodia, flagellum or cilia. They 
enter host cells by penetrating through the host cell plasma membrane or by inducing 
phagocytosis. After entry of tachyzoites into a host cell, there is a variable lag period before 
the parasite divides, and this lag phase is partly parasite strain dependent (Dubey et al, 1998; 
see Figure 1). 
Previous studies in our laboratory determined the impact of vitamin E and selenium 
supplementation in a murine model of toxoplasmosis. Results showed that increased dietary 
supplementation with these two antioxidants resulted in trends towards increased tissue cyst 
number, tissue pathology, and weight loss (McCarthy and Davis, 2003). These results were 
surprising, since dietary supplementation with antioxidants such as vitamin E and selenium 
generally results in an enhancement of the immune response, resulting in increased 
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resistance to a variety of pathogens as well as tumors in animal models and in humans 
(McCarthy and Davis, 2003).  An important question that emerged from our antioxidant 
study was whether vitamin E and selenium might have direct effects on the intracellular 
cycle of T. gondii. We decided to first investigate the impact of selenium exposure on the 
intracellular cycle of the parasite. My role in this investigation was to develop and optimize 
an in vitro cell culture model of infection that would allow us investigate this question. This 
study was conducted using the ME49 strain of T. gondii and a CV-1 (African Green 
Monkey Kidney) mammalian cell line.  An indirect immunofluorescence assay utilizing 
Quantum Dot technology was also developed to allow for accurate visualization and 
quantification of intracellular stages of the parasite. 
 Quantum Dots (QD) are nanometer-sized functional particles that display crystals of 
semiconductor materials, which makes them well suited for visualization and tracking 
(Pathak et al., 2005). They posses a core-shell material, such as CdSe coated with ZnS, and 
are further coated by a polymer shell that allows the materials to be conjugated to biological 
molecules (Lee and et al., 2004). Scientists have developed hybrid functionalized QDs-
liposome nanoparticles and have found that they are efficiently taken up by living cells 
without causing cell death. Therefore, QDs can be used as fluorescent probes for ex vivo cell-
labeling studies with most types of water-soluble QD without further modifications (Figure 
2). Luminescent quantum dot nanoparticles also have emerged as a highly effective 
alternative to organic fluorescence probes in a variety of applications employing the use of 
immuno-conjugates. Quantum Dots (QDs) are able to overcome some of the limitations 
commonly encountered with organic fluorophores such as fading and low signal strength 
(Lee and et al., 2004; Howarth et al., 2005). Brighter signals have been reported in 
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experiments with QD than organic dyes due to greater adsorption of the excitation light and 
the high photobleaching threshold in QDs (Lee and et al., 2004). Also, QDs offer advantages 
such as higher quantum yield, a narrow, tunable and symmetric emission spectrum, and allow 
in vivo imaging.  
Quantum dot-conjugated antibodies have been successfully used for the detection of 
Cryptosporidium parvum and Giardia lamblia in water samples (Zhu et al., 2004).   Another 
study conducted by Tokumasu and Dvorak (2003) demonstrated the applicability of QD 
technique to the study of erythrocyte membrane modifications that occur during invasion by 
Plasmodium spp, the causative agent of malaria. Quantum Dots have also been successfully 
used to detect C. parvum oocytes.  The study conducted by Lee et al. in 2004, clearly 
demonstrated that QDs are highly photostable when compared to other organic dyes such as 
Alexa 488-streptavidin, FITC, and EPA. Immunofluorescent detection of C. parvum oocytes 
using QD-conjugated antibodies was shown to be a highly specific, sensitive, and 
photostable. 
In the present study, we adapted QD technology for the immunofluorescent detection 
of intracellular stages of T. gondii in CV-1 cells. The primary goal of the present study was 
to develop and optimize a Quantum Dot immuno-conjugate technique that would allow for 
reliable, photo-stable detection of intracellular stages of Toxoplasma gondii in an in vitro 
model of infection. 
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Figure 1.   Life cycle of Toxoplasma gondii (from Cambridge University Website) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Examples of QDs’ bioanalytical and biomedical applications. (from International 
Journal of Molecular Science) 
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MATERIALS AND METHODS 
Cell cultures: 
An African Green Monkey Kidney cell line (CV-1) was used for all in vitro cell culture 
experiments. The cells were maintained in sterile RPMI-1640 medium, supplemented with 
10% newborn calf serum and penicillin-streptomycin (all culture reagents from Sigma 
Chemical Company, St Louis, Mo.). The cells were grown in T75 T flasks and were 
incubated at 37ºC with high humidity and 5% CO2
After infected CV-1 cells reached confluency, they were harvested from T flasks using sterile 
ethylenediaminetetraacetic acid buffer (EDTA). Culture supernatants were removed from 
each T flask, and cells were incubated in the presence of 5 ml of sterile EDTA for 5-10 
minutes at 37
.  
 
Parasites: 
The parasite strain used in this study was the Toxoplasma gondii ME49 strain.  The ME49 
strain is maintained in our laboratory by passage in Swiss Webster mice and by infection of 
CV-1 cell monolayers with tachyzoite stages of the parasite. 
 
Preparation of cells for immunofluorescence assay (IFA): 
oC.  Once cells had visibly detached from the T flask, 5mL of complete RPMI-
1640 was added to each flask, and the cells were resuspended by repeated pipetting. The 
resulting cell suspension was then placed into a sterile 15ml centrifuge tube and the tube was 
subjected to centrifugation for 5 minutes at 2000rpm. After decanting the supernatant, the 
cell pellet was re-suspended in 4ml of RPMI-1640. The infected cells were counted using a 
hemacytometer, and the concentration of cells was adjusted to 1.7 x106 cells/ml.  
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Antibody reagents: 
The primary antibody used in the Quantum-dot immunofluourescence assay (Q dot assay) 
was mouse anti-Toxoplasma gondii. Mice in the chronic stages of infection with the ME49 
strain of T. gondii were anesthetized with the inhalant anesthesia isoflurane. Blood was 
obtained by cardiac puncture, and was allowed to clot overnight at 4oC.  Sera were then 
aliquoted and frozen at -20oC until use. The secondary antibody used in all Q dot assays was 
goat anti-mouse IgG conjugated to fluorescent Quantum dots (Invitrogen Corporation, 
Carlsbad, CA). The control primary antibody used in each assay was normal mouse serum.  
 
Lab tech slides: 
Lab Tek Chamber Slides (VWR Corporation, West Chester, PA) were used for all Q dot 
assays. In preparation for the assay, each of the 8 wells on the slide was filled with 250"l of 
the infected cell suspension at a concentration of 1.7 x 106 cells/mL. Cells were cultured 
overnight at 37oC in a CO2
The supernatant of all wells was decanted. Wells were rinsed with 250"l of 1X phosphate 
buffered saline (PBS), and then decanted. Cultured cells were fixed with 4% formalin in PBS 
for 15 minutes. After the 15 minutes incubation, each chamber was washed twice with PBS. 
Cells membranes were permeabilized with 0.25% Triton X (Sigma Chemical Co.) in PBS for 
15 minutes, followed by two washes with PBS. Cells were incubated in a humidity chamber 
with blocking buffer (5% Nonfat Dry Milk in PBS) overnight at 4
 incubator to allow the attachment of the cells to the slide.  
 
Q dot assay: 
Fixation and permeabilization 
oC. Wells were then 
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washed 3 times in PBS, with 5 minute intervals. Cells monolayers were incubated with 
mouse anti-T. gondii antiserum or normal mouse serum for 1 hour at 37oC (at dilutions 
ranging from 1/25 to 1/100 in blocking buffer). Wells were then washed 3 times in PBS, with 
5 minute intervals. Incubation followed with Q dot conjugated secondary antibody (Quantum 
dot conjugated goat anti- mouse IgG) for 1 hour at 37oC (at dilutions of 1/500 or 1/1000). 
Chambers were removed from slides, and slides were washed 3 times in PBS, with 5 minutes 
intervals. Glycerol was added to each slide, and a cover slip was then mounted on the slide. 
 
Imaging 
Slides were viewed on a Zeiss microscope equipped with epifluorescence. Stained cells were 
viewed and photographed at various magnifications (primarily 400X and 1000X) using oil-
immersion lenses with a camera mounted on the microscope. 
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RESULTS 
 
In vitro cell culture model of T. gondii infection 
 The CV-1 (African Green Monkey Kidney) cell line was successfully grown in T-75 
flasks and on LabTek culture slides in the laboratory, and proved to be an excellent in vitro 
model for monitoring the intracellular cycle of T gondii infection (Figure 3).  The CV-1 cell 
line was readily infected with tachyzoite stages of T. gondii, and high numbers of tachyzoite 
stages could be obtained from culture supernatants within two weeks following infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  CV-1 cells infected with tachyzoite stages of T. gondii. Note the 
numerous tachyzoite stages indicated by arrows. (400X) 
 
Control immunofluorescence assays 
Initial assays were performed without primary antibody to determine if there would 
be non-specific binding of the Quantum Dot conjugated secondary antibody.  No non-
 9 
specific binding of secondary antibody was observed at dilutions of 1/500 or 1/1000 in the 
absence of primary antiserum. (see Figure 4).  
 
Immunostaining of intracellular tachyzoite stages of Toxoplasma gondii 
Different concentrations of both primary and secondary antibodies were tested in 
indirect immunofluorescence assays (IFAs) to find the optimal conditions for staining 
intracellular tachyzoite stages. As described above, CV-1 cells infected with tachyzoite 
stages of T.gondii were grown in Lab-Tek culture slides with eight chambers. In the first test 
series, a two-fold dilution of primary antibody (mouse anti-T. gondii or normal mouse serum) 
was used ranging from 1/50 to 1/400. Cells in the top row of four chambers were exposed to 
normal mouse serum.  Cells in the bottom row of four chambers were exposed to the same 
dilutions of mouse anti-T. gondii antiserum. Duplicate Lab-Tek slides were then exposed to 
dilutions of either 1/500 or 1/1000 of the QD-conjugated secondary antibody.  In a second 
assay, a two-fold dilution of primary antibody (mouse anti-T. gondii or normal mouse serum) 
was used ranging from 1/20 to 1/100, with QD-conjugated secondary antibody dilutions at 
1/500 and 1/1000.  Dilutions that showed the greatest fluorescence intensity and specificity, 
with the lowest background staining were the dilutions with 1/50 or 1/100 primary antiserum 
and 1/500 or 1/1000 QD-conjugated secondary antibody. These dilutions of primary and 
secondary antibodies yielded intensely bright, punctate, fluorescent staining at both 400X 
and 1000X magnification without background fluorescence. Representative IFA assay results 
are shown in Figures 5-8. 
The Quantum Dot Immunoconjugate allowed for the reliable, photo-stable detection 
of intracellular stages of Toxoplasma gondii.  Fluorescent staining of tachyzoite stages 
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remained highly photostable even after several minutes of continuous illumination. No 
evidence of photo-bleaching was observed in our assays, even in the absence of anti-fade 
reagents. In addition, fluorescence intensity remained strong even when viewing slides that 
had been stored for a period of several weeks. Quantum dot fluorescence appears to be stable 
for weeks – months.   
                                
 
Figure 4.  Control Immunofluorescence Assay, CV-1 cells infected with T. gondii. No 
primary antibody, 1/500 dilution of secondary antibody (Goat anti-mouse Ig – Quantum Dot 
conjugated). Slides were viewed and photographed using a Zeiss fluorescent microscope. 
Image shown in black/white. 
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Figure 5.  Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.  
Normal Mouse Serum (1/50), 1/500 dilution of secondary antibody (Goat anti-mouse Ig – 
Quantum Dot conjugated). Left panel shown in black/white, Right panel shown in color. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.  
Mouse Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse 
Ig – Quantum Dot conjugated). This image depicts a cell heavily infected with tachyzoite 
stages of T. gondii. Note intense immuno-staining of tachyzoite stages located around the 
nucleus of the infected cell.  Magnification 1000X. 
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Figure 7.  Indirect Immunofluorescence Assay, CV-1 cells infected with T. gondii.  
Mouse Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse 
Ig – Quantum Dot conjugated). Paired Nomarski (left) and fluorescent (right) images of 
heavily infected T. gondii –infected CV-1 cells.  Cells shown in the same field of view.  
400X magnification 
 
 
 
 
                   
 
 
 
 
 
 
            
 
 
 
 
Figure 8.  Indirect Immunofluorescence Assay, CV-1 cell infected with T. gondii.  Mouse 
Anti-T.gondii (1/100 dilution), 1/500 dilution of secondary antibody (Goat anti-mouse Ig – 
Quantum Dot conjugated). This image depicts a CV-1 cell containing tachyzoite stages of T. 
gondii. Note intense, punctate, immuno-staining of tachyzoite stages located around the 
nucleus of the infected cell.  Magnification 1000X. 
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DISCUSSION 
In this study, we successfully adapted QD technology for the immunofluorescent 
detection of intracellular stages of T. gondii in CV-1 cells. Quantum Dots have been proven 
to be useful in immunofluorescence assays because of their photostability, lack of photo-
bleaching, and ease of conjugation to immunoglobulins. In many applications, QDs have 
been shown to be far superior to conventional organic dyes. In the present study we 
confirmed that QDs are highly photo-stable and highly resistant to photo-bleaching. Strong 
fluorescent labeling was still visible for weeks and even months after the initial staining and 
fixing of the slides.  
QDs also have been shown to be useful in a variety of other immuno-labeling studies.  
QD-conjugated antibodies were successfully used for the detection of Cryptosporidium 
parvum and Giardia lamblia in water samples (Zhu et al., 2004).  Two strategies were used. 
In one of the strategies, the target cells were first bound to biotinylated antibodies before 
conjugation of QDs to the cell-bound antibodies. In the second strategy, the authors’ used the 
manufacturer’s recommended staining protocol and the QDs were linked to the antibodies 
prior to addition to the samples. The authors reported that QDs showed better photo-stability 
and higher brightness than the two most commonly used commercial staining kits: a A100DF 
AquaGlo Dual Fluorochrome Kit and a KR1 Crypto-Cel IF test kit. The cells stained with the 
organic dyes bleached rapidly under continuous UV exposure. In contrast, cells labeled with 
QDs remained photostable after 5 minutes of continuous exposure to UV light.  QDs also 
facilitated a dual-color labeling for C .parvum and G .lamblia from various water sources 
(Zhu et al., 2004) 
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Quantum dots have also been used to label erythrocyte membranes and to identify  
modifications occurring in the plasma membrane at the time of infection with Plasmodium 
spp. A QD (QD 650) suspension was diluted to a final concentration of 10-15nM 10 minutes 
prior to use. Erythrocytes were incubated with the QD suspension for 30 minutes. In order to 
label the intracellular malarial stages, 0.1ug ml-1 of a Hoechst 33258 solution containing 
10ug mL-1 of NaN3
In the present study, we have successfully developed and optimized an in vitro cell 
culture model of T. gondii infection that will allow future investigators to readily evaluate the 
infectivity and intracellular replication rate of the parasite. The CV-1 cell line was 
successfully grown in a complete RPMI-1640 medium, and proved to be an excellent host 
cell model for the analysis of the intracellular cycle of T. gondii.   The large size of the cells, 
 was added to the second wash in the assay. A direct comparison of 
Alexa 568 and QD 605 was performed. A 50% decrease in fluorescence was observed in the 
erythrocytes labeled with Alexa 568 after 10 seconds of continuous UV irradiation. In 
contrast, there was no measurable decrease in fluorescence intensity in the QD labeled 
erythrocytes, even after 20 minutes continuous irradiation. In the same study, merozoite 
stages of P. falciparum were also successfully labeled with QD conjugated antibody. This 
immunochemical study was important in furthering our understanding of the intra-
erythrocyte cycle of malaria (Tokumasu and Dvorak, 2003) 
Quantum Dots also have been used successfully for the labeling of C. parvum oocytes 
using QD605-streptavidin together with biotinylated anti-Crypstosporidium monoclonal 
antibody (MAb). The immunofluorescent detection of C. parvum oocytes using QD-
conjugated antibodies was shown to be a highly specific, sensitive, and photostable (Lee et 
al., 2004). 
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and their extended and flattened morphology, allowed for the unambiguous visual detection 
of QD-labeled tachyzoite stages.  Different concentrations of both primary and secondary 
antibodies were tested in indirect immunofluorescence assays (IFAs) to find the optimal 
conditions for staining intracellular stages. The optimal concentrations were found to be 1/50 
and 1/100 dilution of the primary antibody (mouse anti-T. gondii), together with 1/500 or 
1/1000 dilutions of secondary antibody (goat anti-mouse Ig – Quantum Dot conjugated). 
The present study is the first to report of the use of QD technology for the immuno-
fluorescent detection of intracellular tachyzoite stages of T.  gondii. The development and 
optimization of this technique has successfully paved the way for future investigators in the 
laboratory to investigate the impact of selenium and vitamin E exposure on the intracellular 
cycle of T. gondii.  
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